Project Description
CREOPTIX
COMPANY INFO
MEDTECH – Switzerland
COMPANY PROFILE
Creoptix founded in 2009 is based in Wädenswil, Switzerland. The company is specialized in optical instruments and consumables for the label-free analysis of molecular interactions at best-in-class sensitivity for life science research and the drug discovery industry. Creoptix is revolutionizing the study of label-free molecular interactions and changing the world of drug discovery.
NEWS
Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix
Malvern Panalytical, a company providing advanced analysis and services solutions
Creoptix launches new way of measuring kinetics to accelerate drug discovery
Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, has
Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
Wädenswil/Zurich, Switzerland and Saffron Walden, UK, 12th January 2021 / Sciad Newswire / Domainex Ltd.,
Swiss start-ups drive research around Covid-19
Not every Swiss start-up involved in Covid-19 research is developing
Creoptix appoints Line Stigen Raquet as CEO
Wädenswil/Zurich, Switzerland, 10 December 2019 – Creoptix AG, a Switzerland-based
Microfluidics mastery earns Switzerland’s Creoptix $8m Series C
Spare a thought for agri-tech companies out there focused on